SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-128269
Filing Date
2023-12-21
Accepted
2023-12-21 16:45:40
Documents
10
Period of Report
2023-12-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2333217d2_6k.htm 6-K 33766
2 EXHIBIT 3.1 tm2333217d2_ex3-1.htm EX-3.1 1041449
3 EXHIBIT 4.1 tm2333217d2_ex4-1.htm EX-4.1 6232
4 EXHIBIT 10.1 tm2333217d2_ex10-1.htm EX-10.1 454866
5 EXHIBIT 10.2 tm2333217d2_ex10-2.htm EX-10.2 397925
6 EXHIBIT 10.3 tm2333217d2_ex10-3.htm EX-10.3 142091
7 EXHIBIT 99.2 tm2333217d2_ex99-2.htm EX-99.2 14535
8 GRAPHIC tm2333217d2_ex3-1img002.jpg GRAPHIC 7700
9 GRAPHIC tm2333217d2_ex10-2img001.jpg GRAPHIC 9345
10 GRAPHIC tm2333217d2_ex99-2img01.jpg GRAPHIC 5379
  Complete submission text file 0001104659-23-128269.txt   2123295
Mailing Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970
Business Address DR NEERGAARDS VEJ 5F HOERSHOLM G7 2970 004531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 231505905
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)